192 related articles for article (PubMed ID: 21601207)
1. Targeting therapeutics to the vascular wall in atherosclerosis--carrier size matters.
Charoenphol P; Mocherla S; Bouis D; Namdee K; Pinsky DJ; Eniola-Adefeso O
Atherosclerosis; 2011 Aug; 217(2):364-70. PubMed ID: 21601207
[TBL] [Abstract][Full Text] [Related]
2. In vivo evaluation of vascular-targeted spheroidal microparticles for imaging and drug delivery application in atherosclerosis.
Namdee K; Thompson AJ; Golinski A; Mocherla S; Bouis D; Eniola-Adefeso O
Atherosclerosis; 2014 Nov; 237(1):279-86. PubMed ID: 25286447
[TBL] [Abstract][Full Text] [Related]
3. Effect of PEGylation on ligand-based targeting of drug carriers to the vascular wall in blood flow.
Onyskiw PJ; Eniola-Adefeso O
Langmuir; 2013 Sep; 29(35):11127-34. PubMed ID: 23919766
[TBL] [Abstract][Full Text] [Related]
4. Potential role of size and hemodynamics in the efficacy of vascular-targeted spherical drug carriers.
Charoenphol P; Huang RB; Eniola-Adefeso O
Biomaterials; 2010 Feb; 31(6):1392-402. PubMed ID: 19954839
[TBL] [Abstract][Full Text] [Related]
5. Effect of variation in hemorheology between human and animal blood on the binding efficacy of vascular-targeted carriers.
Namdee K; Carrasco-Teja M; Fish MB; Charoenphol P; Eniola-Adefeso O
Sci Rep; 2015 Jun; 5():11631. PubMed ID: 26113000
[TBL] [Abstract][Full Text] [Related]
6. The margination propensity of ellipsoidal micro/nanoparticles to the endothelium in human blood flow.
Thompson AJ; Mastria EM; Eniola-Adefeso O
Biomaterials; 2013 Jul; 34(23):5863-71. PubMed ID: 23642534
[TBL] [Abstract][Full Text] [Related]
7. Recombinant lectin-like domain of thrombomodulin suppresses vascular inflammation by reducing leukocyte recruitment via interacting with Lewis Y on endothelial cells.
Lin WL; Chang CF; Shi CS; Shi GY; Wu HL
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2366-73. PubMed ID: 23950139
[TBL] [Abstract][Full Text] [Related]
8. Adhesive interaction of functionalized particles and endothelium in idealized microvascular networks.
Lamberti G; Tang Y; Prabhakarpandian B; Wang Y; Pant K; Kiani MF; Wang B
Microvasc Res; 2013 Sep; 89():107-14. PubMed ID: 23557880
[TBL] [Abstract][Full Text] [Related]
9. BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis.
Singh KK; Shukla PC; Quan A; Al-Omran M; Lovren F; Pan Y; Brezden-Masley C; Ingram AJ; Stanford WL; Teoh H; Verma S
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):949-960.e4. PubMed ID: 23415688
[TBL] [Abstract][Full Text] [Related]
10. D609 inhibits progression of preexisting atheroma and promotes lesion stability in apolipoprotein e-/- mice: a role of phosphatidylcholine-specific phospholipase in atherosclerosis.
Zhang L; Zhao J; Su L; Huang B; Wang L; Su H; Zhang Y; Zhang S; Miao J
Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):411-8. PubMed ID: 20139365
[TBL] [Abstract][Full Text] [Related]
11. Particle-cell dynamics in human blood flow: implications for vascular-targeted drug delivery.
Charoenphol P; Onyskiw PJ; Carrasco-Teja M; Eniola-Adefeso O
J Biomech; 2012 Nov; 45(16):2822-8. PubMed ID: 23010218
[TBL] [Abstract][Full Text] [Related]
12. Thrombomodulin domains attenuate atherosclerosis by inhibiting thrombin-induced endothelial cell activation.
Wei HJ; Li YH; Shi GY; Liu SL; Chang PC; Kuo CH; Wu HL
Cardiovasc Res; 2011 Nov; 92(2):317-27. PubMed ID: 21840881
[TBL] [Abstract][Full Text] [Related]
13. Specific adhesion and accumulation of VCAM-1-targeted ultrasound microbubbles to inflammatory endothelial cells under hemodynamic shear flow simulation.
Yang H; Zhang L; Xiong X; Liu Y
J Control Release; 2011 Nov; 152 Suppl 1():e227-9. PubMed ID: 22195873
[No Abstract] [Full Text] [Related]
14. A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model.
Gaspari T; Liu H; Welungoda I; Hu Y; Widdop RE; Knudsen LB; Simpson RW; Dear AE
Diab Vasc Dis Res; 2011 Apr; 8(2):117-24. PubMed ID: 21562063
[TBL] [Abstract][Full Text] [Related]
15. Visualization of vascular inflammation in the atherosclerotic mouse by ultrasmall superparamagnetic iron oxide vascular cell adhesion molecule-1-specific nanoparticles.
Michalska M; Machtoub L; Manthey HD; Bauer E; Herold V; Krohne G; Lykowsky G; Hildenbrand M; Kampf T; Jakob P; Zernecke A; Bauer WR
Arterioscler Thromb Vasc Biol; 2012 Oct; 32(10):2350-7. PubMed ID: 22879583
[TBL] [Abstract][Full Text] [Related]
16. Long-term administration of 3-deazaadenosine does not alter progression of advanced atherosclerotic lesions in apolipoprotein E-deficient mice.
Preusch MR; Bea F; Yang SH; Kreuzer J; Isermann B; Pedal I; Rosenfeld ME; Katus HA; Blessing E
J Cardiovasc Pharmacol; 2007 Aug; 50(2):206-12. PubMed ID: 17703138
[TBL] [Abstract][Full Text] [Related]
17. Polymeric particles conjugated with a ligand to VCAM-1 exhibit selective, avid, and focal adhesion to sites of atherosclerosis.
Deosarkar SP; Malgor R; Fu J; Kohn LD; Hanes J; Goetz DJ
Biotechnol Bioeng; 2008 Oct; 101(2):400-7. PubMed ID: 18428114
[TBL] [Abstract][Full Text] [Related]
18. The select cyclooxygenase-2 inhibitor celecoxib reduced the extent of atherosclerosis in apo E-/- mice.
Jacob S; Laury-Kleintop L; Lanza-Jacoby S
J Surg Res; 2008 May; 146(1):135-42. PubMed ID: 17950326
[TBL] [Abstract][Full Text] [Related]
19. Endothelial junctional adhesion molecule-a guides monocytes into flow-dependent predilection sites of atherosclerosis.
Schmitt MM; Megens RT; Zernecke A; Bidzhekov K; van den Akker NM; Rademakers T; van Zandvoort MA; Hackeng TM; Koenen RR; Weber C
Circulation; 2014 Jan; 129(1):66-76. PubMed ID: 24065611
[TBL] [Abstract][Full Text] [Related]
20. In vivo targeting of inflammation-associated myeloid-related protein 8/14 via gadolinium immunonanoparticles.
Maiseyeu A; Badgeley MA; Kampfrath T; Mihai G; Deiuliis JA; Liu C; Sun Q; Parthasarathy S; Simon DI; Croce K; Rajagopalan S
Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):962-70. PubMed ID: 22308043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
